Vitamin E, Beta-Carotene and Vitamin A: study protocols
8 study groups took Vitamin E together with Beta-Carotene and Vitamin A. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin E
6 study groups in 5 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 10 mg to 25 mg, 33% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 1 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 1 |
| 250 mg to 500 mg | 1 |
Dose per serving from research: Beta-Carotene
8 study groups in 6 studies say how much Beta-Carotene participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 38% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg or less | 1 |
| 1 mg to 2.5 mg | 0 |
| 2.5 mg to 5 mg | 2 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 3 |
Commonly used together
7 of 8 study groups took Vitamin E, Beta-Carotene and Vitamin A with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin C | 3 |
8 study groups
| Study | |||||
|---|---|---|---|---|---|
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 11.4 mg | 40 mg | 14,286 IU | 87 weeks | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 11.4 mg | 40 mg | 14,286 IU | 87 weeks | — |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · Liposomal group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 200 IU | 4 mg | — | 90 days | 25 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · MCT group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 200 IU | 4 mg | — | 90 days | 25 |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 200 mg | 25 mg | 500 mcg | 8 weeks | — |
| Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women 2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum | 30 mg | 30 mg | 5,000 IU | — | — |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 400 mg | 25 mg | 50,000 IU | 4 weeks | 63 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 100 mg | 1 mg | 600 mcg | 8 weeks | 41 |